This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,244.19 Firm Fixed Price Delivery Order covers the supply of Insulin Glargine-yfgn U100 Pens with an ultimate completion date of December 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular award was not designated with a set-aside requirement, indicating open competition. The contract aligns with the DLA's role in supplying critical medical commodities, including specialty medications, generic drugs, and medical devices, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/7/25, 10:00 AM